Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease.
Privitera G, Onali S, Pugliese D, Renna S, Savarino E, Viola A, Ribaldone DG, Buda A, Bezzio C, Fiorino G, Fantini MC, Scaldaferri F, Guidi L, Danese S, Gasbarrini A, Orlando A, Armuzzi A.
Privitera G, et al.
J Crohns Colitis. 2020 Jul 17:jjaa149. doi: 10.1093/ecco-jcc/jjaa149. Online ahead of print.
J Crohns Colitis. 2020.
PMID: 32674156